Renal Cell Carcinoma

RENAL CELL CARCINOMA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP

Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates

GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?

New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.

RENAL CELL CARCINOMA NEWS

pills capsules syringe

First-Line Advanced RCC Combo Tx Improves Outcomes Regardless of Prior Surgery

September 23, 2021

Kidney surgery

Preoperative Blood Glucose Level Linked to Length of Stay After Nephrectomy for Renal Cell Carcinoma

September 16, 2021

Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma

August 24, 2021

Welireg Approved for Cancers Associated With Von Hippel-Lindau Disease

August 17, 2021

Keytruda Plus Lenvima Approved for Advanced Renal Cell Carcinoma

August 13, 2021

Next post in Renal Cell Carcinoma

Preoperative Blood Glucose Level Linked to Length of Stay After Nephrectomy for Renal Cell Carcinoma